Ceribell Inc
Research Ceribell Inc (CBLL) on Bullrun: market cap USD 915.45M. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- TickerCBLL
- ExchangeNASDAQ
- CountryUnited States
- SectorHealthcare
- IndustryMedical Devices
- CurrencyUSD
- Market capUSD 915.45M
- Financial periodQ1 2026
- RevenueUSD 26.49M
- Net income-USD 19.74M
- Free cash flow-USD 20.12M
- Gross margin87.3%
Valuation Snapshot
latest market cap is USD 915.45M.
Five-year financial history
| Year | Revenue | Net income | Free cash flow | Gross margin | Diluted EPS | Cash | Total debt | Equity |
|---|---|---|---|---|---|---|---|---|
| FY2025 | USD 89.06M | -USD 53.41M | -USD 41.58M | 87.9% | -1.46 | USD 40.48M | USD 22.28M | USD 155.34M |
| FY2024 | USD 65.44M | -USD 40.46M | -USD 36.38M | 86.7% | -3.39 | USD 194.37M | USD 21.96M | USD 191.17M |
| FY2023 | USD 45.23M | -USD 29.46M | -USD 30.14M | 84.4% | -5.56 | USD 34.50M | USD 14.20M | -USD 112.25M |
Valuation history
| Year | Snapshot date | Market cap | P/E | Dividend yield | Annual dividend/share |
|---|---|---|---|---|---|
| 2026 | 2026-08-25 | USD 915.45M | n/a | n/a | n/a |
| 2025 | 2025-12-31 | USD 822.05M | n/a | n/a | n/a |
| 2024 | 2024-12-31 | USD 927.81M | n/a | n/a | n/a |
About Ceribell Inc
CeriBell, Inc. operates as a medical technology company in the United States. It develops the Ceribell System, a novel and point-of-care EEG platform specifically designed to address the unmet needs of patients in the acute care setting. The company also offers disposable, flexible headbands, and headcaps; and a pocket-sized, rechargeable battery-operated recorder used to capture and wirelessly transmit EEG signals; and Clarity, an AI-powered seizure detection algorithm.
Related stock research
Other Healthcare stocks
Frequently asked questions
What is Ceribell Inc's market cap?
Ceribell Inc's market capitalization is USD 915.45M.
What does Ceribell Inc do?
CeriBell, Inc. operates as a medical technology company in the United States. It develops the Ceribell System, a novel and point-of-care EEG platform specifically designed to address the unmet needs of patients in the acute care setting. The company also offers disposable, flexible headbands, and headcaps; and a pocket-sized, rechargeable battery-operated recorder used to capture and wirelessly transmit EEG signals; and Clarity, an AI-powered seizure detection algorithm. In addition, it operates an EEG portal, which enables real-time remote access to a patient's EEG data.